Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.
